Showing results (291-300 of 1,581) with videos related to

Sort By:
Pageof 159
RSC Medicinal Chemistry|April 26, 2024
Nitrogen-containing andrographolide derivatives with multidrug resistance reversal effects in cancer cellsJoana R L Ribeiro, Nikoletta Szemerédi, Bruno M F Gonçalves, et al.
RSC Medicinal Chemistry|April 26, 2024
Discovery of novel SOS1 inhibitors using machine learningLihui Duo, Yi Chen, Qiupei Liu, et al.
RSC Medicinal Chemistry|April 26, 2024
Recent advances of tryptanthrin and its derivatives as potential anticancer agentsXiaofeng Zhou
RSC Medicinal Chemistry|May 24, 2024
Pyrazolopyridine-based kinase inhibitors for anti-cancer targeted therapyPallabi Halder, Anubhav Rai, Vishal Talukdar, et al.
RSC Medicinal Chemistry|May 24, 2024
A new class of 7-deazaguanine agents targeting autoimmune diseases: dramatic reduction of synovial fibroblast IL-6 production from human rheumatoid arthritis patients and improved performance against murine experimental autoimmune encephalomyelitisMichelle Cotter, Shauna M Quinn, Ursula Fearon, et al.
RSC Medicinal Chemistry|May 24, 2024
Aptamer AS411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancerYuejie Zhu, Xiang Li, Qi Zhang, et al.
RSC Medicinal Chemistry|May 24, 2024
Helical sulfonyl-γ-AApeptides for the inhibition of HIV-1 fusion and HIF-1α signalingXue Zhao, Heng Liu, Justin C Zhang, et al.
RSC Medicinal Chemistry|May 24, 2024
Discovery of new tricyclic spiroindole derivatives as potent P-glycoprotein inhibitors for reversing multidrug resistance enabled by a synthetic methodology-based libraryTao Yu, Rong Zeng, Yu Guan, et al.
RSC Medicinal Chemistry|November 17, 2023
The evolution of small molecule enzyme activatorsLouise F Dow, Alfie M Case, Megan P Paustian, et al.
RSC Medicinal Chemistry|September 21, 2023
En route to local glioblastoma treatment with temozolomide doped hyaluronan fibres: formulation and in vitro cell studiesMarie Belhajová, Aleš Vícha, Ladislav Burgert, et al.
Pageof 159